Lacktman Quoted on Personalized Medicine in Florida
28 January 2011
Tampa Bay Business Journal
Foley Senior Counsel Nathaniel Lacktman was quoted in an article that appeared in the Tampa Bay Business Journal on January 28, 2011 titled “Clinical trials seen as driving economic sector; M2Gen’s presence helping.” Lacktman discusses the efforts of M2Gen, the for-profit subsidiary of Moffitt Cancer Center, to help position the Tampa Bay region as a national leader in drug development. He states that M2Gen’s work should draw drug developers, physicians and other service providers to the area.
People
Related News
11 September 2024
In the News
Cain on Tech M&A Activity – 'VC firms need to have that release valve'
Foley & Lardner LLP partner Christopher Cain assessed M&A activity in the technology sector in the Mergers & Acquisitions article, "Tech M&A’s Uneven Comeback: Winners and Losers are Segment-Specific."
06 September 2024
In the News
Natasha Allen on California AI Legislation – 'California definitely wants to be on the forefront'
Foley & Lardner LLP partner Natasha Allen commented on recent California legislative action designed to regulate the development and deployment of artificial intelligence in the Law360 article, "Calif. Takes AI Reins With Looming Safety, Transparency Laws."
06 September 2024
In the News
Old Employment Law Principles Can Answer New AI Concerns
The integration of artificial intelligence into the workplace has sparked a flurry of legal and regulatory discussions in recent months.